A Study of Drug Content and Cell Cytotoxicity of Paclitaxel-eluting Stents Coated with Various Biopolymer.
- Author:
Dong Gon KIM
1
;
Il Gyun SHIN
;
Gi Han KIM
;
Seong Hyeon KIM
;
Ju Ho LEE
;
Byoyng Yun KI
;
Jae Woon NAH
;
Tae Suk SUH
;
Sang Ho KIM
Author Information
1. Institute of Interventional Medicine, M. I. Tech Co., Lnc, Pyeongtaek,Korea.
- Publication Type:In Vitro ; Original Article
- Keywords:
Drug eluting stent;
Paclitaxel;
Biopolymer;
Restenosis;
Drug contents
- MeSH:
Biopolymers;
Cell Line;
Colon;
Gastrointestinal Diseases;
Lactic Acid;
Molecular Weight;
Paclitaxel;
Polyglycolic Acid;
Polymers;
Silicone Elastomers;
Stents
- From:Korean Journal of Medical Physics
2009;20(3):125-131
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
In this study, the paclitaxel eluting stent (PES) was prepared by coating a biliary stent with paclitaxel using various biopolymer such as poly (vinyl acetate) (PVAc), poly (lactic-co-glycolic acid) (PLGA), Silicone rubber for restenosis prevention in gastrointestinal disease by a dip-coating method. Drug contents of PES were increased as surface area of stent, concentration and molecular weight of coating polymer increase. In 1H-NMR specta, we know that drug did not change by confirming specific peaks of paclitaxel in PES. As shown in SEM image, PES prepared using various biopolymer is coated clearly and regularly except Silicone rubber coating polymer. In in vitro cell cytotoxicity test, bare stent showed low cytotoxic effect against CT-26 colon carcinoma cell line on 3 day. However, PES coated with PLGA 502H showed the highest cytotoxicity because PLGA 502H is biodegradable polymer and has less molecular weight than other coating polymer. These results suggest that PES coated various biopolymer can be prevented restenosis in gastrointestinal disease.
